Skip Navigation LinksHome > February 2014 - Volume 114 - Issue 2 > Hydrocodone: A New Recommendation And A New Drug
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000443797.94461.ab
Drug Watch

Hydrocodone: A New Recommendation And A New Drug

Aschenbrenner, Diane S. MS, RN

Collapse Box

Abstract

* The Food and Drug Administration is recommending that drugs containing the narcotic hydrocodone be reclassified as schedule II controlled substances, indicating that they carry a higher potential for abuse than was previously believed.

* The agency also recently approved an extended-release form of hydrocodone, Zohydro ER, as a single entity for the treatment of severe and chronic pain when other treatment options have been inadequate.

* Like other extended-release and long-acting narcotics, Zohydro ER's labeling will carry strong warnings of its potential for abuse or overdose and its possible adverse effects.

© 2014 Lippincott Williams & Wilkins. All rights reserved.

Login